Stem Cell Therapy for Rheumatoid Arthritis

Rheumatoid Arthritis (RA) is a chronic inflammatory condition where the body's immune system mistakenly attacks the lining of the joints. This leads to inflammation, stiffness, swelling, and pain. Unlike other types of arthritis, RA typically affects both sides of the body, particularly the hands, wrists, and knees. In addition to joint damage, RA can impact other body systems, including the nerves, blood vessels, heart, eyes, lungs, and skin.

Rheumatoid Arthritis (RA) is an autoimmune disorder where the immune system mistakenly attacks the body's tissues, particularly in the joints. This leads to the destruction of the joint lining, resulting in swelling, stiffness, and pain. Over time, this process can cause bone damage and joint deformity.

Severe cases of Rheumatoid Arthritis (RA) are a leading cause of physical disabilities and can also contribute to psychiatric symptoms.

The exact cause of Rheumatoid Arthritis remains unknown. However, clinical evidence suggests a potential genetic link. While genes alone do not cause RA, they may predispose an individual to develop the condition in response to other factors, such as infections or environmental triggers.

Rheumatoid Arthritis (RA) presents differently in each person. Some individuals may experience long periods with few or mild symptoms, while others suffer from flares, where symptoms significantly intensify for months at a time. Over time, most people progressively develop more severe episodes.

Although the exact cause of Rheumatoid Arthritis (RA) is not fully understood, certain factors may increase the likelihood of developing the disease:

Family History: Having a family member with rheumatoid arthritis can increase your risk of developing RA.

Sex: Women are more likely to develop RA than men.

Age: RA is most commonly diagnosed in middle-aged individuals, but it can occur at any age.

Smoking: Smoking is linked to a higher risk of developing RA, and the risk is even greater for those with a family history or genetic predisposition.

Overweight: Excess weight is associated with an increased risk of developing RA

Rheumatoid Arthritis (RA) presents differently in each person. Some individuals may experience long periods with few or mild symptoms, while others suffer from flares, where symptoms significantly intensify for months at a time. Over time, most people progressively develop more severe episodes.

Joint Symptoms:

RA primarily affects the joints, often starting in the hands but also impacting other joints such as the elbows, wrists, fingers, knuckles, and ankles. It can also occur in the toes, hips, jaw, knees, neck, and shoulders.

Early Signs:

RA's first signs can appear within weeks or months, eventually leading to the typical symptoms:

• Pain: Joints hurt whether moving or at rest.
• Swelling: Fluid accumulation in the joints causes puffiness.
• Tenderness: Joints are painful to touch.
• Stiffness: Joints feel stiff, especially in the morning, with stiffness lasting more than an hour.
• Redness and Warmth: Inflammation can cause joints to be warmer and change color.

Systemic Symptoms:

RA affects more than just the joints. It can lead to fatigue, muscle pain, low appetite, general discomfort, and even depression.

Skin:

Some individuals develop rheumatoid nodules, which are painful bumps that typically appear under the skin on the elbows, but they can also be found on the forearms, back of the head, tendons, and base of the spine.

Heart and Lungs:

RA can cause complications in organs, bones, and blood vessels. Inflammation may affect the lining around the lungs, causing chest pain and shortness of breath. Over time, RA may lead to stiffening of lung tissues, making breathing difficult.

A similar inflammatory process can occur around the heart or within its muscle, increasing the risk of heart failure and stroke.

Eyes: Common eye complications include cataracts, dry eye syndrome, and inflammation of the white part of the eye (scleritis).

Other Parts of the Body: The long-term effects of Rheumatoid Arthritis, along with the chemicals in medications used to treat it, can harm various parts of the body, including the bones, immune system, muscles, nerves, blood vessels, liver, and kidneys.

The American College of Rheumatology has developed recommendations for the treatment of Rheumatoid Arthritis (RA) to delay or prevent disease progression and reduce loss of function and joint damage. Treatment options may include biological agents and other substances, such as anti-inflammatory drugs, non-steroidal anti-inflammatory drugs (NSAIDs), immune modulators, and, in some cases, surgery. While these treatments can offer limited or temporary relief from pain and slow disease progression, they cannot repair damaged tissues.

Clinical literature suggests that exosomes combined with mesenchymal stem cells (MSCs) can help in autoimmune diseases by regulating inflammatory cytokines, the microenvironment, and immune cells. This process significantly impacts both adaptive and innate immune cells, particularly macrophages, Treg cells, Th17 cells, immunoregulatory miRNAs, and CD4+Th1 cells.

Exosomes combined with mesenchymal stem cells (MSCs) assist in regulating T-cell subsets in autoimmune diseases. Specifically, MSC-derived exosomes help reduce the levels and concentrations of pro-inflammatory cytokines, including Th17 and Th1 cytokines such as IL-17AF, IL-12p70, and IL-6. Additionally, these exosomes enhance the concentration of anti-inflammatory Treg cells.

Mesenchymal stem cell-derived exosomes (MSCs-Exosomes) increase the concentration of Treg cells and related products without altering the lymphocyte concentration index, thereby maintaining immunoregulation in the body. This regulatory effect is observed in conditions such as rheumatoid arthritis (RA) and graft-versus-host disease (GVHD).

In GVHD, MSCs-Exosomes improve outcomes by suppressing the differentiation of naïve T-cell populations. Macrophages, which are a crucial component of the innate immune system, can also be regulated through MSCs-Exosome administration. Depending on the microenvironment, naïve macrophages (Mo) can be polarized into either anti-inflammatory (M2) or pro-inflammatory (M1) states to fulfill different roles under varying conditions.

In addition to their benefits in autoimmune conditions, MSCs-Exosomes also facilitate metabolic homeostasis, helping to reduce obesity and adipose inflammation. Furthermore, they promote the conversion of M1 macrophages to M2 macrophages, thereby reducing pro-inflammatory factors associated with the M1 macrophage state.

The primary objective of stem cell therapy (SCT) is to offer patients an effective treatment that stimulates their immune system and promotes tissue regeneration in affected areas. This approach helps alleviate the symptoms of rheumatoid arthritis (RA) without the adverse effects and risks associated with other treatment options.

SCT is a highly effective and viable alternative for patients whose current interventions or other treatments do not sufficiently improve their symptoms.

Stem Cell Therapy (SCT) is the most innovative and advanced treatment option for Rheumatoid Arthritis.

SCT's main objective is to provide patients with a satisfactory treatment that stimulates their immunity and promotes tissue regeneration in affected areas. It helps improve the associated symptoms of RA without the adverse effects and risks of the other treatment options.

SCT is a highly effective and viable option for patients when their current intervention or other treatments do not improve symptoms.

Stem Cell Therapy (SCT) at The Renue Centre is a holistic approach to treating Rheumatoid Arthritis. It can potentially repair RA -affected joint tissues, restoring function and effectively preventing RA's progression.

Your Renue Journey does not end after your last day of SCT. We follow up with you to assert your progress, following three phases:

Pre-treatment:

RA symptoms clinical evaluation, flare-up frequency, lab test results, and RA -related results

All your medical records will be uploaded by your Patient Advisor for the doctor to review.

You will take our TruDiagnostics Epigenetic Test that will assert your biological age and other important health markers. Your TruDiagnostics test is part of The Renue Difference. It provides your doctor with critical information about your health and your true age (biological vs. chronological).

After the epigenetic test and we have received all your medical records, your Patient Advisor will assist you in planning your travel to Puerto Vallarta.

30, 60 & 90 days post-treatment follow-up: RA symptoms clinical evaluation, flare-up frequency, and lab test results.

Six months post-treatment: RA symptoms clinical evaluation, flare-up frequency, lab test results, X-ray report, and review of the diagnostic criteria from the American College of Rheumatology

SCT to live a better life: Benefits and outcomes

The effectiveness of Stem Cell Treatment can improve all your symptoms, causing a considerable impact on your quality of life and daily activities.

As part of The Renue Difference, you will receive three Hyperbaric Chamber sessions that greatly improve SCT efficacy and stimulate the body cells to combat Rheumatoid Arthritis (RA). These sessions comprise three days: one day before treatment, after treatment, and on the day of treatment.

According to results, clinical outcomes, and pre and post-treatment observations, SCT has been shown to help

Reduce RA progression

Speed up tissue repair

Regrow and repair tissues after six months

After the SCT procedure, an MRI test depicts the further need for the treatment at a specific body site.

Talk to our Patient Advisor to learn more about SCT at the Renue Centre.

The Stem Cell Therapy risks are low and infrequent because of the therapy's high safety domain.

The most frequent or possible adverse effects post-SCT treatment can be:

Allergic reactions

Fever

Fatigue or lethargy

Painful injection site